|
nasopharyngeal carcinoma |
37 |
|
prognostic factors |
14 |
|
chemotherapy |
12 |
|
intensity-modulated radiation therapy |
12 |
|
staging |
12 |
|
treatment outcomes |
12 |
|
imrt |
11 |
|
radiotherapy |
11 |
|
prognosis |
10 |
|
medical sciences |
9 |
|
prognostication |
9 |
|
efficacy |
8 |
|
non-metastatic |
8 |
|
oncology |
8 |
|
plasma ebv dna |
8 |
|
adult |
7 |
|
aged |
7 |
|
aged, 80 and over |
7 |
|
female |
7 |
|
humans |
7 |
|
late toxicity |
7 |
|
meta-analysis |
7 |
|
middle aged |
7 |
|
sequence |
7 |
|
survival rate |
7 |
|
adaptive planning |
6 |
|
dosimetric predictors |
6 |
|
hong kong |
6 |
|
hypothyroidism |
6 |
|
local clinical remission |
6 |
|
multidisciplinary |
6 |
|
nasopharyngeal cancer |
6 |
|
neoplasm staging |
6 |
|
nomogram |
6 |
|
post-treatment plasma ebv dna |
6 |
|
postradiation malignancies |
6 |
|
retrospective studies |
6 |
|
risk factors |
6 |
|
staging system |
6 |
|
treatment outcome |
6 |
|
diffusion weighted imaging |
5 |
|
disease-free survival |
5 |
|
early detection |
5 |
|
epidemiology |
5 |
|
intensity-modulated radiotherapy |
5 |
|
magnetic resonance imaging |
5 |
|
mastectomy, segmental |
5 |
|
radiology and nuclear medicine |
5 |
|
salvage treatment |
5 |
|
stretched exponential |
5 |
|
treatment |
5 |
|
young adult |
5 |
|
breast - anatomy & histology |
4 |
|
breast cancer |
4 |
|
breast neoplasms |
4 |
|
breast neoplasms - pathology - radiography - radiotherapy - surgery |
4 |
|
chemoradiotherapy |
4 |
|
chi-square distribution |
4 |
|
conservation |
4 |
|
hyperfractionation |
4 |
|
igrt |
4 |
|
impt |
4 |
|
intensity‐modulated radiotherapy |
4 |
|
local recurrence |
4 |
|
locally advanced recurrence |
4 |
|
mammography - psychology - utilization |
4 |
|
mastectomy, segmental - trends |
4 |
|
masticator space |
4 |
|
organ size |
4 |
|
re-irradiation |
4 |
|
reirradiation |
4 |
|
standard fractionation |
4 |
|
surgery |
4 |
|
tnm staging |
4 |
|
tnm staging system |
4 |
|
toxicities |
4 |
|
toxicity |
4 |
|
ace-27 |
3 |
|
adolescent |
3 |
|
age factors |
3 |
|
altered fractionation |
3 |
|
asian continental ancestry group |
3 |
|
breast carcinoma |
3 |
|
breast conservation therapy |
3 |
|
breast neoplasms - epidemiology - genetics - pathology |
3 |
|
breast neoplasms - epidemiology - genetics - pathology - surgery |
3 |
|
breast neoplasms - mortality - surgery |
3 |
|
breast neoplasms - radiography - surgery |
3 |
|
carcinoma - epidemiology - genetics - pathology - secondary - surgery |
3 |
|
carcinoma, ductal - epidemiology - genetics - pathology |
3 |
|
carcinoma, lobular - epidemiology - genetics - pathology |
3 |
|
co-morbidity |
3 |
|
comorbidity |
3 |
|
concurrent-adjuvant |
3 |
|
cost-benefit analysis |
3 |
|
cranial nerve palsy |
3 |
|
dose escalation |
3 |
|
elderly |
3 |
|
feasibility studies |
3 |
|
follow-up studies |
3 |
|
gene amplification |
3 |
|
gene expression profiling |
3 |
|
genes, erbb-2 |
3 |
|
hong kong - epidemiology |
3 |
|
image-guidance radiotherapy |
3 |
|
immunohistochemistry |
3 |
|
in situ hybridization - methods |
3 |
|
in situ hybridization, fluorescence |
3 |
|
induction-concurrent |
3 |
|
lymphatic metastasis |
3 |
|
male |
3 |
|
mammography |
3 |
|
mammography - economics |
3 |
|
mastectomy |
3 |
|
mastectomy - statistics & numerical data |
3 |
|
mastectomy, modified radical |
3 |
|
nasopharyngeal neoplasms - radiotherapy |
3 |
|
neoplasm recurrence, local |
3 |
|
neoplasm recurrence, local - radiography |
3 |
|
neoplasm staging - methods |
3 |
|
patient selection |
3 |
|
radiotherapy dosage |
3 |
|
radiotherapy, conformal - methods |
3 |
|
randomized trial |
3 |
|
receptor, epidermal growth factor |
3 |
|
risk |
3 |
|
risk assessment |
3 |
|
risk assessment - methods |
3 |
|
survival analysis |
3 |
|
therapeutic benefit |
3 |
|
tnm |
3 |
|
automatic segmentation |
2 |
|
clinical target volume |
2 |
|
delineation |
2 |
|
dose constraints |
2 |
|
gross target volume |
2 |
|
guideline |
2 |
|
head and neck cancer |
2 |
|
intensity-modulated |
2 |
|
organs at risk |
2 |
|
prostate cancer |
2 |
|
prostate neoplasms |
2 |
|
prostate-specific antigen |
2 |
|
prostatic neoplasms - radiotherapy |
2 |
|
radiometry - methods |
2 |
|
radiotherapy planning, computer-assisted - methods |
2 |
|
rapidarc |
2 |
|
reproducibility of results |
2 |
|
sensitivity and specificity |
2 |
|
software |
2 |
|
airway obstruction |
1 |
|
airway obstruction - etiology |
1 |
|
antimetabolites, antineoplastic - administration & dosage |
1 |
|
antineoplastic agents, phytogenic - administration & dosage |
1 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
1 |
|
chemotherapy, adjuvant |
1 |
|
fibroma - complications - drug therapy - radiography |
1 |
|
fibromatosis, aggressive |
1 |
|
head and neck neoplasms |
1 |
|
head and neck neoplasms - complications - drug therapy - radiography |
1 |
|
methotrexate - administration & dosage |
1 |
|
vinblastine - administration & dosage |
1 |
